MedPage Today on MSN
New Kink in the Link Between GLP-1 Drugs and Cognition
By extending survival, GLP-1 agents may expand the dementia risk period for diabetes patie ...
Oklahoma researchers found the hormone FGF21 targets the same brain region as GLP-1 drugs, but works by boosting metabolic ...
MetaVia begins patient dosing in Part 3 of phase 1 study of DA-1726, a GLP-1 and glucagon dual agonist to treat obesity: Cambridge, Massachusetts Monday, April 13, 2026, 11:00 Hrs ...
Week Study Evaluates One-Step Dose Titration to 48 mg and Two-Step Dose Titration to 64 mg in Obese Otherwise Healthy Adults CAMBRIDGE, Mass., April 10, 2026 /PRNewswire/ ...
The Drugs Consultative Committee (DCC), during its 68th meeting, deliberated on strengthening regulatory oversight and ...
A hormone that reverses obesity in mice appears to work by signaling to a brain region involved in metabolism and appetite regulation, the same area targeted by the popular GLP-1 drugs. The finding, ...
The Chosun Ilbo on MSN
GLP-1 in joints suggests direct arthritis treatment pathway
A research team from Aarhus University in Denmark has confirmed for the first time that the hormone GLP-1, used in obesity ...
Gan & Lee Pharmaceuticals (hereinafter referred to as "Gan & Lee", SSE: 603087) announced the signing of an exclusive ...
JW Pharmaceutical has introduced a glucagon-like peptide-1 (GLP-1) class anti-obesity drug candidate that is administered once every two weeks from China's Gan & Lee Pharmaceuticals. The company said ...
GLP-1 drugs like Wegovy alone do not work, may benefit more from a combination treatment, a recent review of the evidence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results